US 12258372
Recombinant vaccine against Marek's disease and Newcastle disease
granted A61KA61K2039/543A61K2039/552
Quick answer
US patent 12258372 (Recombinant vaccine against Marek's disease and Newcastle disease) held by The United States of America, as represented by the Secretary of Agriculture expires Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary of Agriculture
- Grant date
- Tue Mar 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K2039/543, A61K2039/552, A61K38/00, A61K39/12